Inaktiver Wert

SCHERING-PLOUGH Aktie

Aktien

Schlusskurs Nyse Andere Börsenplätze
- ^USD	-

SCHERING-PLOUGH : Announces Sponsorship of Rabies-Control Projects in India	02.11.09
SCHERING-PLOUGH : Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies	02.11.09
SCHERING-PLOUGH : U.S. Food and Drug Administration Issues Complete Response Letter Regarding PEGINTRON(R) for Malignant Melanoma	30.10.09
SCHERING-PLOUGH : Standard & Poor's Announces Changes to U.S. Indices	29.10.09
SCHERING-PLOUGH : troisième trimestre en ligne avec les attentes	22.10.09

Sektor

	% 1. Jan.	Kap.
CSL LIMITED	-4.66%	86.13 Mrd.
SAMSUNG BIOLOGICS CO.,LTD.	+1.32%	39.82 Mrd.
BIOGEN INC.	-19.27%	30.42 Mrd.
UCB	+57.86%	25.23 Mrd.
BIOMARIN PHARMACEUTICAL INC.	-16.09%	15.35 Mrd.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.14%	11.95 Mrd.
INCYTE CORPORATION	-17.69%	11.6 Mrd.
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43.00%	11.51 Mrd.
SWEDISH ORPHAN BIOVITRUM AB	+5.24%	8.71 Mrd.